AVITA Medical, Inc.

ASX:AVH

AVITA Medical, Inc.

ASX:AVH
TradeAdd trade order Follow Unfollow Set Price Alert
$3.81 (+1.6%)
Last close price
#80
Rank
8
Held by
24
Followers
TradeAdd trade order Follow Unfollow Set Price Alert
Reports (4) My Report Forum Investors
Top member reports
Consensus
mmff
Company Report
Last edited 4 years ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#135
Performance (52m)
-15.4% pa
Followed by
155
Follow Unfollow
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
Become a member
#Q2FY21 Results 11/2/21
stale
mmff
Added 4 years ago
View author's company report

AVITA Medical Reports Full Second Quarter 2021 Financial Results

Second Quarter Highlights

~ Reported U.S based RECELL® revenue of $5.0 million in the second quarter of 2021 ended December 31, 2020, a 62% increase over the same quarter in the prior year

~ Reported total global revenue of $5.1 million in the second quarter of 2021 ended ~ecember 31, 2020, a 57% increase over the same quarter in the prior year

~Commercial metrics: o Procedural volumes were 487 in the second quarter of 2021 versus 496 in the prior quarter ended September 30, 2020 o Added 7 new accounts in the second quarter 2021 for a total of 93 accounts

~ Enrolled nine patients in the pivotal study assessing the use of the RECELL® System to treat stable vitiligo

View Attachment